Barclays PLC Glaukos Corp Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Glaukos Corp stock. As of the latest transaction made, Barclays PLC holds 89,699 shares of GKOS stock, worth $14.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

89,699

Previous 89,699 -0.0%

Holding current value

$14.1 Million

Previous $11.7 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$113.62 - $135.39 $8.13 Million - $9.69 Million	71,556 Added 394.4%	89,699 $11.7 Million
Q2 2024 Aug 14, 2024	SELL	$89.48 - $118.35 $2.18 Million - $2.89 Million	-24,386 Reduced 57.34%	18,143 $2.15 Million
Q1 2024 May 15, 2024	SELL	$76.4 - $96.33 $9.27 Million - $11.7 Million	-121,369 Reduced 74.05%	42,529 $4.01 Million
Q4 2023 Feb 15, 2024	BUY	$59.53 - $85.11 $7.02 Million - $10 Million	117,859 Added 256.0%	163,898 $13 Million
Q3 2023 Nov 07, 2023	BUY	$69.23 - $79.09 $828,890 - $946,944	11,973 Added 35.15%	46,039 $3.47 Million
Q2 2023 Aug 03, 2023	BUY	$45.44 - $71.21 $492,569 - $771,916	10,840 Added 46.67%	34,066 $2.43 Million
Q1 2023 May 04, 2023	BUY	$43.88 - $52.48 $29,794 - $35,633	679 Added 3.01%	23,226 $1.16 Million
Q4 2022 Feb 13, 2023	BUY	$40.82 - $57.75 $336,479 - $476,033	8,243 Added 57.63%	22,547 $985,000
Q3 2022 Nov 03, 2022	SELL	$46.84 - $58.49 $1.16 Million - $1.45 Million	-24,801 Reduced 63.42%	14,304 $761,000
Q2 2022 Aug 12, 2022	SELL	$34.86 - $63.77 $21.5 Million - $39.3 Million	-616,808 Reduced 94.04%	39,105 $1.78 Million
Q1 2022 May 16, 2022	SELL	$44.33 - $57.82 $4.01 Million - $5.23 Million	-90,508 Reduced 12.13%	655,913 $37.9 Million
Q4 2021 Feb 14, 2022	BUY	$40.27 - $56.99 $24.6 Million - $34.8 Million	610,732 Added 450.1%	746,421 $33.2 Million
Q3 2021 Nov 09, 2021	BUY	$47.43 - $84.23 $5.17 Million - $9.19 Million	109,048 Added 409.32%	135,689 $6.54 Million
Q2 2021 Aug 13, 2021	SELL	$73.06 - $97.7 $2.19 Million - $2.93 Million	-30,030 Reduced 52.99%	26,641 $2.26 Million
Q1 2021 May 13, 2021	BUY	$70.43 - $97.42 $522,520 - $722,758	7,419 Added 15.06%	56,671 $4.76 Million
Q4 2020 Feb 11, 2021	SELL	$48.9 - $75.26 $879,319 - $1.35 Million	-17,982 Reduced 26.75%	49,252 $3.71 Million
Q3 2020 Nov 12, 2020	BUY	$37.23 - $50.97 $1.06 Million - $1.45 Million	28,493 Added 73.55%	67,234 $3.33 Million
Q2 2020 Aug 12, 2020	BUY	$28.78 - $46.83 $183,414 - $298,447	6,373 Added 19.69%	38,741 $1.49 Million
Q1 2020 May 13, 2020	SELL	$25.53 - $70.14 $166,659 - $457,873	-6,528 Reduced 16.78%	32,368 $999,000
Q4 2019 Feb 10, 2020	BUY	$54.18 - $65.64 $1.08 Million - $1.31 Million	19,966 Added 105.47%	38,896 $2.12 Million
Q3 2019 Nov 14, 2019	SELL	$58.58 - $83.91 $2.55 Million - $3.66 Million	-43,584 Reduced 69.72%	18,930 $1.18 Million
Q2 2019 Aug 14, 2019	BUY	$63.59 - $78.71 $3.02 Million - $3.74 Million	47,456 Added 315.15%	62,514 $4.71 Million
Q1 2019 May 15, 2019	BUY	$50.75 - $80.54 $500,141 - $793,721	9,855 Added 189.41%	15,058 $1.18 Million
Q4 2018 Feb 14, 2019	SELL	$52.18 - $67.93 $2.04 Million - $2.65 Million	-39,049 Reduced 88.24%	5,203 $292,000
Q3 2018 Nov 14, 2018	BUY	$38.13 - $68.37 $599,441 - $1.07 Million	15,721 Added 55.1%	44,252 $2.87 Million
Q2 2018 Aug 14, 2018	BUY	$27.62 - $44.51 $623,908 - $1.01 Million	22,589 Added 380.16%	28,531 $1.16 Million
Q1 2018 May 15, 2018	SELL	$26.05 - $34.5 $43,737 - $57,925	-1,679 Reduced 22.03%	5,942 $183,000
Q4 2017 Feb 14, 2018	SELL	$24.5 - $36.01 $81,854 - $120,309	-3,341 Reduced 30.48%	7,621 $196,000
Q3 2017 Nov 14, 2017	BUY	$31.26 - $42.03 $342,672 - $460,732	10,962	10,962 $362,000

Others Institutions Holding GKOS

# of Institutions

352

Shares Held

46.8M

Call Options Held

132K

Put Options Held

188K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.48B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account